Skip to content

Neuropsychological Norms for Ethnically Diverse Florida Elders

Neuropsychological Norms for Ethnically Diverse Florida Elders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03199378
Enrollment
350
Registered
2017-06-26
Start date
2016-06-03
Completion date
2017-09-01
Last updated
2017-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The goal of this proposal is to collect normative data from a sample of ethnically diverse Florida elders on a brief, standardized neuropsychological test battery . The norms collected in this multi-cultural dataset will provide appropriate corrections for demographic and sociocultural variables that contribute to performance variance on neuropsychological tests. By accounting for these variables, the normative corrections will improve specificity and eliminate disparities in diagnostic validity and clinical utility of neuropsychological tests when administered to Florida's ethnic minority elders.

Interventions

OTHERNeuropsychological Testing

Each group will be administered a battery of neuropsychological tests

Sponsors

Mayo Clinic
CollaboratorOTHER
Mt. Sinai Medical Center, Miami
CollaboratorOTHER
Florida Department of Health
CollaboratorOTHER_GOV
University of South Florida
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 105 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 60 or above. * Any gender. * Primary language of English or Spanish. * Self-identifies as Hispanic, non-Hispanic Black/African American, or non-Hispanic Caucasian. * Global Clinical Dementia Rating (CDR) score = 0.

Exclusion criteria

* Memory decline reported by participant, informant (if available), or study clinician. * Currently uncontrolled health condition that could affect cognition. * Abnormal findings on current neurologic examination. * History of chronic neurological diseases (stroke, active seizure disorder, parkisonism, TBI with subsequent cognitive change. * Current substance abuse or history of substance dependence. * History of chronic psychiatric disease (Bipolar disorder, schizophrenia). * Currently active mood disorder. History of depression or anxiety is acceptable if symptoms are controlled (Score \<6 on the Geriatric Depression Scale). If taking psychoactive mood medication dosage must be stable for at least one month prior to testing. * Use of cognitive enhancing medications (i.e. cholinesterase inhibitors, memantine). * Need for assistance in activities of daily living due to cognitive reasons. * Sensorimotor deficits that would interfere with ability to perform neuropsychological tests.

Design outcomes

Primary

MeasureTime frameDescription
Neuropsychological norms1 yearNorm referenced scores from the sample population

Countries

United States

Contacts

Primary ContactJohn Lucas, Ph.D
lucas.john@mayo.edu904-953-2000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026